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Introduction
Health is one of the main indicators of life quality and 
the essential factor of sustainable development of society. 
As in the case of other countries, the health care system 
in Moldova must respond to new needs, appeared from 
demographic and socio-cultural changes, globalization 
process and rapid progress of medical technologies.
 Pharmacists  are the  most often visited and accessible 
members of the health care team, being visited by sick 
and healthy people. For example, in the countries of the 
European Union, the 107.000 pharmacists serve 343.3 
million of the population. Of this number about 17 million 
visit the pharmacy daily [1].
The pharmacist undertakes his/her own responsibility 
for each prescription, which he/she must check. He is the 
professional of health making up the last link in the way 
of the drug, guiding the patient against its misuse. The 
guarantee of quality and safety brought by the pharmacist 
is a true foundation that he consents the preparation and 
releasating of the drug [2].
Purpose. The problem being presented, is proposed to 
be analyzed to highlight the specifics of the pharmaceutical 
activity and research the errors committed by pharmacists 
to develop recommendations for their prevention.
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Abstract
Background: Healthcare professionals are not fully aware of the harm caused by medication errors in terms of patient discomfort and economic burden. 
The problem being presented, we propose the analysis of the specificity of the pharmaceutical activity and the research of the errors committed by the 
pharmacists for the elaboration of the recommendations for their prevention. 
Material and methods: This research is a meta-analysis in which it quantitatively combined the results from previous studies to obtain a summary value. 
The research was carried out in 4 stages: identification, selection, extraction and data analysis. 
Results: Studying the specialized literature we identified great gaps in the knowledge of the actual data about the frequency of medication errors and 
their classification. Quality research is needed to determine the effectiveness of the following interventions: implementation of efficient and qualitative 
tools that will contribute to reducing medication errors; educational interventions regarding risk factor management; developing an anonymous system 
for reporting medication errors; review of the schedule, workload and conditions under which pharmacists work.
Conclusions: Medication errors require clear and unambiguous definitions where patients, doctors, manufacturers, and regulators will understand each 
other. The pharmacists’ ethics manifests itself in honest acknowledgment of their mistakes, because in this profession, as in no other profession, the 
slightest inaccuracy will lead to serious consequences and can be fatal for the patient.
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Material and methods
This research is a meta-analysis in which the results from 
previous studies have been combined to obtain a summary 
value. The research was divided into 4 stages: identification, 
selection, extraction and analysis of data.
At the first stage, were identified all the articles corre-
sponding to the subject under investigation. After collecting 
the articles followed the selection of true information from 
them and the extraction of relevant data. Finally, all the data 
were analyzed and conclusions were formulated.
Results and discussion
Studying the literature we have identified large gaps in 
the knowledge of current data about the frequency of medi-
cation errors and their classification. Quality researches are 
needed to determine the effectiveness of the following in-
terventions, which would help to prevent medication errors:
·	Computerized systems through which the doctor can 
complete and transmit the pharmacy recipes online 
and who can also check according to drug allergy and 
drug interactions, and, as well and as quickly inform 
about warnings regarding the correlation of prescrip-
tions with the patient’s condition. This system will 
make much  easier the  pharmacist’s work, and due to 
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its speed, overloads of the pharmacist will be avoided;
·	Educational interventions according to  the manage-
ment of factors which contribute to the occurrence of 
medication errors;
·	Developing an anonymous system for reporting medi-
cation errors;
·	 Improving the level of professional knowledge of 
pharmacists;
·	Double check by pharmacists of prescription drugs 
before release;
·	The involvement of pharmacists in reporting the fac-
tors that cause them to make errors;
·	The review of the program, the volume of work and 
the conditions under which pharmacists work.
The activity of the pharmacist in the open-circuit phar-
macy is that of counseling the patient in mild conditions 
that do not require consultation with the doctor and guid-
ance to the doctor where the gravity of the situation imposes 
advice on how to administer the medication recommended 
by the doctor [3], warning of potential adverse reactions 
and side effects (for example: gastric discomfort / gastroin-
testinal ulcer in the case of  NSAID, intolerance to certain 
substances, possible teratogenic effects when administer-
ing certain drugs to pregnant women, especially in the first 
trimester of pregnancy), information on combinations of 
medicines or foods that may decrease the effectiveness of 
medication (for example: concomitant administration of 
oral contraceptives with tetracyclines, vitamin C, combina-
tion of tetracyclines with dairy foodstuffs or salts of Ca2+, 
Al3+, Fe2+, Bi3+, Mg2+ – oral antacids), warning on some 
associations  contraindicated or those done with precau-
tions (for example: combination of NSAID at patients in 
treatment with oral anticoagulants, or at the patients with 
asthma with/without allergic component, association of 
beta-blockers (non-selective propranolol) at patients with 
hypoglycaemic therapy or  selective at persons in  treatment 
with anti-asthmatic or antidepressant medicinal products 
(for antidepressants, only for lipophilic beta blockers), the 
usage of caffeine-containing drinks or OTC medicines in 
gout patients) [4].
The pharmacist who works in an open-circuit pharmacy 
can play an important role in education of the population 
both in terms of OTC medication, as well as in the treatment 
recommended by the doctor, showing the professionalism 
and promptness in providing the information as clearly 
as possible, in a language accessible to the patient [5]. His 
role is not only to release the drug, but also to ensure that 
the information he transmits with its release has been fully 
understood, that the treatment scheme will be respected 
and as in the case of undesirable or serious manifestations 
the patient will contact the doctor or pharmacist as soon as 
possible [6].
All these and many other activities are part of the spe-
cifics of pharmaceutical activity that is always at risk. At 
first, the main risk to which pharmacists were exposed was 
related to the usual threats lurking in a business (thefts, 
fires, etc.), and also to negligence regarding errors in the 
release of the recipes. Now, modern pharmaceutical prac-
tice must take into account new risks, related to the usage 
of technologies and electronic data transmission, patient 
counseling and requirements for evaluating the administra-
tion of medicines as well as confidential health information. 
Pharmaceutical practice evolves, and with it increases the 
risks related to the changing environment and objectives. 
Pharmacists should be conscious of the inherent risks of the 
provision of medical products and services and develop risk 
management strategies to counteract them [7]. All these 
risks have negative consequences of medication errors that 
can have a negative impact on patients’ lives.
The problem of medical and pharmaceutical errors 
has been and remains one of the most important in the 
field of healthcare in many countries of the world. One of 
these problems was the terrible “tragedy of thalidomide” 
(from 1956 to 1962), when after thalidomide prescribing 
at pregnant women were born up to 12 thousand children 
with congenital malformations [8] and it was after this time 
that special pharmacovigilance services were created for the 
first time in several countries of the world to identify and 
prevent complications of drug therapy.
In the Republic of Moldova studies have not been 
conducted that reflect the statistics of medication errors, but 
the analysis of similar data from other countries shows that:
-	in the United States of America, the pharmacists 
make 4-12 mistakes out of 100 cases of drugs delivery, 
about 87% of errors are caused by incorrect reading 
of a recipe, the confusion on behalf of medicinal 
products and packaging design [9];
-	in community pharmacies in the United Kingdom, 
the errors of drugs releasing constituted 0.01-3.32% 
[10];
-	in Denmark were identified up to 0.6% of prescriptions 
containing medication errors, but 8.7% of them can 
lead to deaths [11].
According to Professor N. Schaad of the University of 
Medicine in Geneva, the medication errors represent any 
mistake in prescribing, releasing or administration of a 
medicinal product, whether these errors lead to negative 
consequences or not [12]. Practically it is an action made 
incorrectly or due to ignorance, caused by a miscalculation, 
writing, speech, law or failure to perform an action that was 
planned, as well as using a wrong action plan to achieve a 
goal.
Cognitive psychologists believe that errors, lapses are 
the price we pay for superior brain function and those 
errors are inevitable. Ernest Mach (1838 - 1916) was saying 
“knowledge and error flow from the same mental source, 
only success can differentiate them”[13].
In 2013, Ivan Anosov, an employee of the Department 
of pharmaceutical Management and Economics of the 
Friendship University of Russia [14], made a research for 
identifying the typical mistakes that pharmacists commit in 
their practice. This study classified the errors as follows:
-	the error associated with the name of the drug – 
34.4%;
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-	releasing of a wrong medicinal product – 22.1%;
-	releasing children’s medicines to an adult patient and 
vice versa – 15.3%;
-	the error in calculating the dose, the concentration of 
the drug – 10.4%;
-	the error in replacing the drug with an analogue – 
9.8%;
-	the recommendation and  drug releasing which are 
not in accordance with the indications – 8.0%.
 Regarding the last two types of errors mentioned above, 
was made a study in the Republic of Moldova in 2015 on 
the Ethical promotion of medicines: current approaches and 
regulations [15], in which 1000 people were questioned.  At 
the question “Did the pharmacist suggest you should buy 
a drug other than the one recommended/prescribed by the 
doctor?” 22% of respondents answered: “Yes, very often”; 
54.4 % of respondents answered: “Yes, sometimes”; 22.4 % 
of respondents answered: “No”.
  Based on the survey we attest the existence of the 
situations when pharmacists suggest buying other medicine 
than the one recommended/prescribed by the doctor.  The 
changing of the doctor’s option by the pharmacist can be 
based on various reasons: the lack of the product in the 
pharmacy, the encouragement of sales of a particular drug 
of a particular pharmaceutical company, etc.
At the question “Did the pharmacist insist to buy in 
addition to the medicine/s requested some other medicine/s?” 
15.4 % of respondents answered: “Yes, very often”; 28.2 
% of respondents answered: “Yes, sometimes”; 56.2 % of 
respondents answered: “No”. The majority of respondents 
said that the pharmacist did not insist on other drugs besides 
those requested. However, there are also respondents who 
have dealt with proposals from the pharmacist on the 
purchase of an add-on drug.
There is a difference between the attitude of a person 
who is not in the pharmaceutical field and the attitude of 
a pharmacist to his professional mistakes [16], and that is:
1. The pharmacist has a tendency to objectify the source 
of errors. His own thinking way, like that of a doctor, is 
dialectical and dynamic.
2. At patients, is often observed an opposite tendency 
– to see the omnipotent pharmaceutical science, but the 
source of errors is only in the pharmacist incompetence 
or in the unwillingness to help the patient. The thinking 
way of healthy and sick patients is logical-mechanical and 
statistical.
In order to understand how medication errors are com-
mitted and to develop methods of prevention their classifi-
cation will be taken into account, what can be contextual, 
according to the mechanism of production and psychologi-
cal. Contextual classification includes specific time, place, 
drugs and involved people. The classification according to 
the production mechanism examines how errors occur (e. 
g. by omission, repetition or replacement). However, is pref-
erable the classification based on psychological theory be-
cause it explains the events and their description. According 
to this theory, medication errors can be classified as follows:
Category A: there are circumstances and events that are 
capable of causing errors;
Category B: an error has occurred, but the error does 
not affect the patient;
Category C: an error which affects the patient has 
occurred, but the error does not cause a harmful response 
to the patient;
Category D: an error affecting the patient has occurred 
and monitoring is required to confirm that the error does 
not cause a harmful response to the patient and / or the 
required intervention is required to exclude harmfulness;
Category E: an error affecting the patient occurred and 
may have contributed to or resulted in a temporary harmful 
response of the patient and no intervention was required;
Category F: an error that has occurred may have 
contributed or resulted in a temporary harmful response 
of the patient and was imposed an initial hospitalization or 
prolongation of hospitalization;
Category G: an error that has occurred may have 
contributed or resulted in a permanent harmful response of 
the patient;
Category H: an error that occurred may have required 
an intervention to support the patient’s life;
Category I: an error that occurred may have contributed 
to or resulted in the patient’s death [17, 18]. 
According to the mechanism of production, pharma-
ceutical errors are divided into (fig. 1):
	Errors produced by  the pharmacist;
	Errors in which the pharmacist has not a fault.
All these errors can be committed by a huge range of 
drugs (20 thousand products), at the same time, too many 
medicines have similar orthographic names: tamiflu-thera-
flu, linex-linkas, somnil-sonmil, prostamol-paracetamol, 
ranitidine-remantadine, etc. As well as the similarities be-
tween the packaging of medicines (e.g. Cyston and Liv-52) 
or the same medicine, but in different doses. Pharmacists 
can also be influenced by tiredness, haste, overwork, illness, 
household problems, insufficient sleep or by conflicting pa-
tients. All these reduce the attention and can have negative 
effects on the patient’s health.
 Another cause of errors is the lack of qualified personnel. 
By the beginning of this year, there were about 1400 
pharmacies in the Republic of Moldova, and their number 
is constantly increasing.   About 80-90 specialists graduate 
from Nicolae Testemitsanu State University of Medicine and 
Pharmacy annually and only four out of ten of them work 
in pharmacies. According to the data, the number of non-
professional employees in pharmaceutical organizations 
reaches 40%  [20, 21]. On account of the acute deficiency of 
specialists, employers had to lower the requirements to the 
professional level of employees.
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Conclusions
The medication errors require clear and unambiguous 
definitions, so that patients, doctors, manufacturers and 
regulatory authorities can understand each other.
The classification of medication errors based on how 
they occur, may suggest strategies that will help reduce their 
occurrence.
The ethics of the pharmacists is manifested in the honest 
recognition of their mistakes, because in this profession, as 
in no other profession, the slightest inaccuracy results in 
serious consequences and can be fatal for the patient.
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